{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:15:07Z","timestamp":1773278107564,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T00:00:00Z","timestamp":1163462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,3,14]]},"DOI":"10.1007\/s00259-006-0276-2","type":"journal-article","created":{"date-parts":[[2006,11,13]],"date-time":"2006-11-13T11:40:35Z","timestamp":1163418035000},"page":"487-495","source":"Crossref","is-referenced-by-count":64,"title":["Combined PET\/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?"],"prefix":"10.1007","volume":"34","author":[{"given":"Michael","family":"Zoller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Kohlfuerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Igerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewald","family":"Kresnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Gallowitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,14]]},"reference":[{"key":"276_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00259-003-1403-y","volume":"31","author":"M Iwata","year":"2004","unstructured":"Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, et al. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPECT, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 2004;31:491\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"276_CR2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","volume":"26","author":"F Gr\u00fcnwald","year":"1999","unstructured":"Gr\u00fcnwald F, K\u00e4licke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26:1547\u201352.","journal-title":"Eur J Nucl Med"},{"key":"276_CR3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s002590050158","volume":"24","author":"M Dietlein","year":"1997","unstructured":"Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24:1342\u20138.","journal-title":"Eur J Nucl Med"},{"key":"276_CR4","first-page":"414","volume":"42","author":"T Shiga","year":"2001","unstructured":"Shiga T, Tsukamoto E, Nakada K, Morita K, Kato T, Mabuchi M, et al. Comparison of 18F-FDG, 131I-Na, and 201Tl in diagnosis of recurrent or metastatic thyroid carcinoma. J Nucl Med 2001;42:414\u20139.","journal-title":"J Nucl Med"},{"key":"276_CR5","first-page":"1468","volume":"37","author":"U Feine","year":"1996","unstructured":"Feine U, Lietzenmayer R, Hanke JP, Held J, W\u00f6hrle H, M\u00fcller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37:1468\u201372.","journal-title":"J Nucl Med"},{"key":"276_CR6","first-page":"71","volume":"42","author":"B Schl\u00fcter","year":"2001","unstructured":"Schl\u00fcter B, Bohuslavizki KH, Beyer W, Plotkin M, Buchert R, Clausen M. Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan. J Nucl Med 2001;42:71\u20136.","journal-title":"J Nucl Med"},{"key":"276_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/105072502760339307","volume":"12","author":"J Sch\u00f6nberger","year":"2002","unstructured":"Sch\u00f6nberger J, R\u00fcschoff J, Grimm D, Marienhagen J, R\u00fcmmele P, Meyringer R, et al. Glucose transporter 1 gene expression is related to thyroid neoplasm with an unfavoreable prognosis: an immunhistochemical study [abstract]. Thyroid 2002;12:747\u201354.","journal-title":"Thyroid"},{"key":"276_CR8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/thy.1999.9.797","volume":"9","author":"PS Conti","year":"1999","unstructured":"Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 1999;9:797\u2013804.","journal-title":"Thyroid"},{"key":"276_CR9","first-page":"115","volume":"26","author":"P Lind","year":"1999","unstructured":"Lind P, Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Kumnig G, et al. Comparison of different tracers in the follow up of differentiated thyroid carcinoma. Acta Med Austriaca 1999;26:115\u20138.","journal-title":"Acta Med Austriaca"},{"key":"276_CR10","first-page":"870","volume":"39","author":"HJ Gallowitsch","year":"1998","unstructured":"Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998;39:870\u20135.","journal-title":"J Nucl Med"},{"key":"276_CR11","first-page":"348","volume":"38","author":"P Lind","year":"1997","unstructured":"Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1997;38:348\u201352.","journal-title":"J Nucl Med"},{"key":"276_CR12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004230050109","volume":"383","author":"G Altenvoerde","year":"1998","unstructured":"Altenvoerde G, Lerch H, Kuwert T, Matheja P, Sch\u00e4fers M, Schober O. Positron emission tomography with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 1998;383:160\u20133.","journal-title":"Langenbecks Arch Surg"},{"key":"276_CR13","first-page":"1010","volume":"41","author":"NS Alnafisi","year":"2000","unstructured":"Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 2000;41:1010\u20135.","journal-title":"J Nucl Med"},{"key":"276_CR14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1259\/bjr\/31538331","volume":"76","author":"N Khan","year":"2003","unstructured":"Khan N, Oriuchi N, Higuchi T, Zhang H, Endo K. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003;76:690\u20135.","journal-title":"Br J Radiol"},{"key":"276_CR15","first-page":"1464","volume":"42","author":"OB Helal","year":"2001","unstructured":"Helal OB, Merlet P, Toubert ME, Franc B, Schvartz C, Gauthier-Koelesnikov H, et al. Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy. J Nucl Med 2001;42:1464\u20139.","journal-title":"J Nucl Med"},{"key":"276_CR16","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s002590100626","volume":"28","author":"SN Reske","year":"2001","unstructured":"Reske SN, Kotzerke J. FDG-PET for clinical use: results of the 3rd German interdisciplinary consensus conference, \u201cOnko-PET III\u201d, 21 July and 19 September 2000. Eur J Nucl Med 2001;28:1707\u201313.","journal-title":"Eur J Nucl Med"},{"key":"276_CR17","first-page":"297","volume":"46","author":"SC Ong","year":"2005","unstructured":"Ong SC, Ng DCE, Sundram FX. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography\/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans. Singapore Med J 2005;46:297\u2013301.","journal-title":"Singapore Med J"},{"key":"276_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mhn.2003.74","volume":"128","author":"LA Zimmer","year":"2003","unstructured":"Zimmer LA, McCook B, Meltzer C, Fukui M, Bascom D, Snyderman C, et al. Combined positron emission tomography\/computed tomography imaging of recurrent thyroid cancer. Otolaryngol Head Neck Surg 2003;128:178\u201384.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"276_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mlg.0000154725.00787.00","volume":"115","author":"Z Nahas","year":"2005","unstructured":"Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, et al. The role of positron emission tomography\/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 2005;115:237\u201343.","journal-title":"Laryngoscope"},{"key":"276_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/thy.2005.15.158","volume":"15","author":"A David","year":"2005","unstructured":"David A, Blotta A, Rossi R, Zatelli MC, Bondanelli M, Roti E, et al. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid 2005;15:158\u201364.","journal-title":"Thyroid"},{"key":"276_CR21","first-page":"1989","volume":"41","author":"F Moog","year":"2000","unstructured":"Moog F, Linke R, Manthey N, Tiling R, Knesewitsch P, Tatsch K, et al. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med 2000;41:1989\u201395.","journal-title":"J Nucl Med"},{"key":"276_CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00259-001-0745-6","volume":"29","author":"T Petrich","year":"2002","unstructured":"Petrich T, B\u00f6rner AR, Otto D, Hofmann M, Knapp WH. Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002;29:641\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"276_CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072502760043459","volume":"12","author":"KM Tol Van","year":"2002","unstructured":"Van Tol KM, Jager PL, Piers DA, Pruim J, De Vries EGE, Dullaart RPF, et al. Better yield of 18Fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation [abstract]. Thyroid 2002;12:381\u20137.","journal-title":"Thyroid"},{"key":"276_CR24","first-page":"1843","volume":"36","author":"GC Scott","year":"1995","unstructured":"Scott GC, Meier DA, Dickinson CZ. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide. J Nucl Med 1995;36:1843\u20135.","journal-title":"J Nucl Med"},{"key":"276_CR25","doi-asserted-by":"crossref","unstructured":"Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET\/CT. Eur J Nucl Med Mol Imaging 2005 (DOI 10.1007\/s00259-005-0018-x ).","DOI":"10.1007\/s00259-005-0018-x"},{"key":"276_CR26","first-page":"1623","volume":"40","author":"H Schirrmeister","year":"1999","unstructured":"Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glattnig G, Rentschler M, et al. Sensitivity in detecting osseus lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med 1999;40:1623\u20139.","journal-title":"J Nucl Med"},{"key":"276_CR27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1148\/radiol.2372031994","volume":"237","author":"Y Nakamoto","year":"2005","unstructured":"Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. CT appearance of bone metastases detected with FDG PET as part of the same PET\/CT examination. Radiology 2005;237:627\u201334.","journal-title":"Radiology"},{"key":"276_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00259-001-0737-6","volume":"29","author":"D Simon","year":"2002","unstructured":"Simon D, K\u00f6rber C, Krausch M, Segering J, Groth P, G\u00f6rges R, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002;29:775\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"276_CR29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1530\/eje.0.1480395","volume":"148","author":"T Gr\u00fcning","year":"2003","unstructured":"Gr\u00fcning T, Tiepolt C, Z\u00f6phel K, Bredow J, Kropp J, Franke WG. Retinoic acid for redifferentiation of thyroid cancer\u2014does it hold its promise? Eur J Endocrinol 2003;148:395\u2013402.","journal-title":"Eur J Endocrinol"},{"key":"276_CR30","first-page":"752","volume":"46","author":"T Ishimori","year":"2005","unstructured":"Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET\/CT. J Nucl Med 2005;46:752\u20137.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0276-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-006-0276-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0276-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:58:58Z","timestamp":1558713538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-006-0276-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3,14]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0276-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,14]]}}}